SenzaGen AB (SENZA.ST)

SEK 5.26

(-0.38%)

Revenue Summary of SenzaGen AB

SenzaGen AB's latest annual revenue in 2023 was 49.87 Million SEK , up 19.39% from previous year.
SenzaGen AB's latest quarterly revenue in 2024 Q1 was 14.33 Million SEK , down -45.43% from previous quarter.
SenzaGen AB reported a annual revenue of 41.77 Million SEK in annual revenue 2022, up 170.85% from previous year.
SenzaGen AB reported a annual revenue of 15.42 Million SEK in annual revenue 2021, up 93.79% from previous year.
SenzaGen AB reported a quarterly revenue of 14.33 Million SEK for 2024 Q1, down -45.43% from previous quarter.
SenzaGen AB reported a quarterly revenue of 26.27 Million SEK for 2023 Q4, up 100.0% from previous quarter.

Annual Revenue Chart of SenzaGen AB (2023 - 2014)

Historical Annual Revenue of SenzaGen AB (2023 - 2014)

Year	Revenue	Revenue Growth
2023	49.87 Million SEK	19.39%
2022	41.77 Million SEK	170.85%
2021	15.42 Million SEK	93.79%
2020	7.95 Million SEK	192.14%
2019	2.72 Million SEK	36.4%
2018	1.99 Million SEK	73.2%
2017	1.15 Million SEK	131.53%
2016	498 Thousand SEK	-71.51%
2015	1.74 Million SEK	7.64%
2014	1.62 Million SEK	0.0%

Year	Revenue	Revenue Growth
2024 Q2	14.66 Million SEK	2.29%
2024 Q1	14.33 Million SEK	-45.43%
2023 Q4	26.27 Million SEK	100.0%
2023 Q2	23.59 Million SEK	91.95%
2023 FY	49.87 Million SEK	19.39%
2023 Q1	12.29 Million SEK	-43.74%
2023 Q3	13.13 Million SEK	-44.31%
2022 Q2	19.92 Million SEK	100.0%
2022 Q4	21.84 Million SEK	100.0%
2022 FY	41.77 Million SEK	170.85%
2022 Q1	9.96 Million SEK	-4.29%
2022 Q3	10.92 Million SEK	-45.17%
2021 Q2	5.01 Million SEK	100.0%
2021 FY	15.42 Million SEK	93.79%
2021 Q4	10.4 Million SEK	100.0%
2021 Q3	5.2 Million SEK	3.76%
2021 Q1	2.5 Million SEK	-39.26%
2020 Q1	1.91 Million SEK	78.64%
2020 FY	7.95 Million SEK	192.14%
2020 Q4	4.12 Million SEK	100.0%
2020 Q3	2.06 Million SEK	-46.11%
2020 Q2	3.83 Million SEK	100.0%
2019 Q3	536 Thousand SEK	-67.55%
2019 Q2	1.65 Million SEK	100.0%
2019 Q1	826 Thousand SEK	-64.86%
2019 FY	2.72 Million SEK	36.4%
2019 Q4	1.07 Million SEK	100.0%
2018 FY	1.99 Million SEK	73.2%
2018 Q1	2.41 Million SEK	-16.06%
2018 Q2	2.41 Million SEK	0.0%
2018 Q3	2.35 Million SEK	-2.69%
2018 Q4	2.35 Million SEK	0.0%
2017 Q2	2.41 Million SEK	0.0%
2017 FY	1.15 Million SEK	131.53%
2017 Q3	2.87 Million SEK	18.95%
2017 Q1	2.41 Million SEK	170.58%
2017 Q4	2.87 Million SEK	0.0%
2016 FY	498 Thousand SEK	-71.51%
2016 Q3	894 Thousand SEK	71.26%
2016 Q2	522 Thousand SEK	0.0%
2016 Q1	522 Thousand SEK	0.0%
2016 Q4	894 Thousand SEK	0.0%
2015 FY	1.74 Million SEK	7.64%
2014 FY	1.62 Million SEK	0.0%

Peer Revenue Comparison of SenzaGen AB

Name	Revenue	Revenue Difference
AroCell AB (publ)	43.03 Million SEK	-15.872%
Devyser Diagnostics AB (publ)	169.3 Million SEK	70.543%
Immunovia AB (publ)	1.57 Million SEK	-3066.349%
Prostatype Genomics AB (publ)	1.35 Million SEK	-3577.729%
Spermosens AB	- SEK	-Infinity%